NCT01381861 2019-03-05Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaTracon Pharmaceuticals Inc.Phase 2 Completed23 enrolled 12 charts